First Conference with the Egyptian Ortho Club
Al Kenz Pharmaceuticals Announces the Launch of Mukosat® and Hosts First Conference with the Egyptian Ortho Club
Dubai, UAE — [01-12-2025]
Al Kenz Pharmaceuticals officially announced the launch of Mukosat®, a new advancement in joint-health therapy, marking a significant step forward in the company’s expansion across the UAE healthcare market.
The launch represents a major milestone for Al Kenz Pharmaceuticals as it continues to build a strong portfolio of high-quality, evidence-based pharmaceutical solutions designed for modern clinical needs.
A Strategic Collaboration with the Egyptian Ortho Club
To celebrate the launch, Al Kenz Pharmaceuticals hosted its first scientific conference in collaboration with the Egyptian Ortho Club, welcoming a distinguished group of orthopaedic specialists, surgeons, and rehabilitation experts.
The conference served as a professional platform to exchange knowledge, explore innovations in joint-care treatment, and discuss emerging challenges in musculoskeletal health.
“We are honored to introduce Mukosat to the UAE and to launch it alongside such a respected community of orthopaedic professionals. This collaboration reflects our long-term commitment to advancing medical education and supporting clinicians across the region.”
Spokesperson from Al Kenz Pharmaceuticals
Advancing Conversations in Joint-Care Therapy
During the event, medical experts addressed key topics including:
- ● Modern approaches to managing joint degeneration
- ● Clinical insights and real-world case experiences
- ● The growing need for safe, effective, and long-term joint-support therapies
The discussions highlighted how innovation and collaboration play an essential role in improving long-term patient outcomes.
Strengthening Education and Regional Partnerships
The event concluded with strong engagement from medical professionals and reinforced the company’s strategic vision to expand scientific and educational initiatives throughout the Middle East.
As Mukosat® enters the UAE market, Al Kenz Pharmaceuticals is preparing a series of medical education programs, professional collaborations, and awareness initiatives to support healthcare professionals.
With the successful launch of Mukosat® and the first conference held in partnership with the Egyptian Ortho Club, Al Kenz Pharmaceuticals is setting a strong foundation for future growth, innovation, and impact in the field of joint-care therapy.
